Patents by Inventor Astrid Nagell

Astrid Nagell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amorphous silibinin for the treatment of viral hepatitis
    Patent number: 8614341
    Abstract: The invention relates to a method for the preparation of amorphous silibinin (or its synonyms: silybin or silibin) derived from a milk thistle fruit extract having an increased release rate and improved absorbability or bioavailability, and to the use of amorphous silibinin for the treatment or prevention of liver diseases, preferably for the treatment of viral hepatitis, e.g. hepatitis B or C, in particular in a patient who will undergo or has undergone liver transplantation. Preferably, the amorphous silibinin is adapted for oral administration.
    Type: Grant
    Filed: May 14, 2010
    Date of Patent: December 24, 2013
    Assignee: Euromed S.A.
    Inventors: Lucio Claudio Rovati, Astrid Nagell, Aguirre Jaime Xiol, Prous Santiago Rull, Ralf-Torsten Pohl, Ulrich Mengs
  • AMORPHOUS SILIBININ FOR THE TREATMENT OF VIRAL HEPATITIS
    Publication number: 20120108825
    Abstract: The invention relates to a method for the preparation of amorphous silibinin (or its synonyms: silybin or silibin) derived from a milk thistle fruit extract having an increased release rate and improved absorbability or bioavailability, and to the use of amorphous silibinin for the treatment or prevention of liver diseases, preferably for the treatment of viral hepatitis, e.g. hepatitis B or C, in particular in a patient who will undergo or has undergone liver transplantation. Preferably, the amorphous silibinin is adapted for oral administration.
    Type: Application
    Filed: May 14, 2010
    Publication date: May 3, 2012
    Applicant: Euromed S.A.
    Inventors: Lucio Claudio Rovati, Astrid Nagell, Aguirre Jaime Xiol, Prous Santiago Rull, Ralf-Torsten Pohl, Ulrich Mengs
  • NOVEL MILK THISTLE EXTRACT, METHOD FOR THE PRODUCTION, AND USE
    Publication number: 20110027396
    Abstract: A method for preparing a milk thistle fruit extract, in particular a flavanolignan preparation, has an increased release rate and improved absorbability. A pharmaceutical preparation contains the extract and is used, in particular for the treatment and prevention of liver diseases.
    Type: Application
    Filed: December 23, 2008
    Publication date: February 3, 2011
    Applicant: EUROMED SA
    Inventors: Astrid Nagell, Jaime Xiol Aguirre, Santiago Rull Prous